Nike Price Targets Diverge as Analysts Debate the Pace of Recovery
Barclays lifted its Nike price target to $45 from $37 while leaving earnings estimates unchanged, and Wolfe Research began coverage with an Underperform rating and a $28 target. Nike closed at $38.32 on Oct. 22, about 5% above the average Street target of $36.50, after its October guidance reset lowered consensus forecasts for fiscal 2027 and beyond. Analysts are watching whether lifestyle demand recovers before the company can return to growth.
Barclays’ Oct. 22 move lifted its Nike target to $45 from $37 after management meetings, though that remains under the $48 it had before the Oct. 1 update. Wolfe began coverage at Underperform with a $28 target. Nike closed at $38.32 that day, roughly 5% above the $36.50 average Street target.
After the Oct. 1 guidance, consensus fiscal 2027 revenue dropped 5.6% to $42.8 billion by Oct. 23, while fiscal 2028 fell 7.5% to $43.3 billion; later years saw similar cuts. FY2027 normalized EPS consensus of $1.28 sits inside Nike’s $1.15–$1.35 adjusted range, excluding about $0.15 of Pace costs.
Nike’s split analyst views could affect retail investors and pension savers exposed through index funds, as price swings influence portfolio values. A slower recovery may also shape hiring, supplier orders, and brand partners’ planning, while consumers could see continued discounting or product changes. Because Nike is a large global brand, its performance may color sentiment toward apparel and consumer discretionary stocks, though direct societal effects are likely indirect and gradual.